When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNCE - Jounce up 41% after hours on revised Celgene collaboration
Jounce Therapeutics Inc.
Jounce Therapeutics (NASDAQ:JNCE) is up 41% after hours in reaction to its updated partnership with Celgene (NASDAQ:CELG) under which the latter has in-licensed global rights to JTX-8064, an LILRB2 receptor-targeting monoclonal antibody.
More news on: Jounce Therapeutics, Inc., Celgene Corporation, Healthcare stocks news, Stocks on the move,